David Good
Impact in
- Physical and Theoretical Chemistry top 0.5%
- Crystallography and molecular interactions
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
Papers in
-
- Lymphoma Diagnosis and Treatment 14
- Hematology 10
- Acute Myeloid Leukemia Research 5
- Co-authors
- Naír Rodríguez‐Hornedo (3 shared papers)Adivaraha Jayasankar (1 shared paper)Randy D. Gascoyne (3 shared papers)Michael J. Rauh (10 shared papers)John R. Crison (4 shared papers)Fazlur Rahman (1 shared paper)Richard Burack (1 shared paper)Jane L. Liesveld (1 shared paper)
- Journals
- Blood (8 papers)Hematology/Oncology Clinics of North America (2 papers)Leukemia Research (2 papers)Molecular Pharmaceutics (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
David Good
33 papers receiving 1.2k citations
David Good's Hit Papers
Peers
Comparison fields: 5 of 94
- Physical and Theoretical Chemistry 680
- Pharmaceutical Science 190
- Materials Chemistry 729
- Dermatology 87
- Inorganic Chemistry 116
Countries citing papers authored by David Good
This map shows the geographic impact of David Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Good more than expected).
Fields of papers citing papers by David Good
This network shows the impact of papers produced by David Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Good. The network helps show where David Good may publish in the future.
Co-authors
The 25 scholars most cited alongside David Good, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Solubility Advantage of Pharmaceutical Cocrystals Hit paper breakdown → | 2009 | 754 |
| 2 | 2007 | 115 | |
| 3 | 2011 | 70 | |
| 4 | 2018 | 38 | |
| 5 | 2009 | 34 | |
| 6 | 2010 | 29 | |
| 7 | 2015 | 26 | |
| 8 | 2016 | 19 | |
| 9 | 2018 | 17 | |
| 10 | 2008 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2008 | 15 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 14 | |
| 15 | 2017 | 13 | |
| 16 | 2015 | 9 | |
| 17 | 2011 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2014 | 8 | |
| 20 | 2022 | 8 |
About David Good
David Good is a scholar working on Pathology and Forensic Medicine, Hematology, Molecular Biology, Genetics and Oncology, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Drug Solubulity and Delivery Systems (5 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Viral-associated cancers and disorders (4 papers), Cutaneous lymphoproliferative disorders research (4 papers), Crystallization and Solubility Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Physical and Theoretical Chemistry (680 citations), Pharmaceutical Science (190 citations), Materials Chemistry (729 citations), Dermatology (87 citations) and Inorganic Chemistry (116 citations). David Good has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Naír Rodríguez‐Hornedo, Adivaraha Jayasankar, Randy D. Gascoyne, Michael J. Rauh, John R. Crison, Fazlur Rahman, Richard Burack, Jane L. Liesveld, Nikolay Dimov and John M. Bennett. Their work appears in journals such as Blood, Hematology/Oncology Clinics of North America, Leukemia Research, Molecular Pharmaceutics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.